Literature DB >> 33653363

Label-free proteomics uncovers SMC1A expression is Down-regulated in AUB-E.

Yingxian Jia1, Jie Luo1, Yibing Lan1, Chunming Li1, Linjuan Ma1, Xiaoming Zhu1, Fei Ruan2, Jianhong Zhou3.   

Abstract

BACKGROUND: While heavy menstrual bleeding (HMB) is a prevalent symptom among women with abnormal uterine bleeding caused by endometrial disorder (AUB-E) seeking gynecologic care, the primary endometrial disorder remains poorly understood.
METHODS: Five human endometrial samples from women with AUB-E and the age-matched healthy women were selected, respectively. Proteins from the samples were analyzed by a linear ion trap (LTQ)-Orbitrap Elite mass spectrometer based label-free proteomic approach. The purpose protein was validated by western blot and immunohistochemistry staining.
RESULTS: A total of 2353 protein groups were quantified under highly stringent criteria with a false discovery rate of < 1% for protein groups, and 291 differentially expressed proteins were significantly changed between the two groups. The results showed that the down-regulation of structural maintenance of chromosomes protein 1A (SMC1A) in AUB-E patients. Next, this change in the glandular epithelial cells was validated by immunohistochemistry.
CONCLUSION: The results indicated a novel mechanism for the cause of AUB-E, as down-expression SMC1A potentially regulated the cell cycle progression in endometrial glandular epithelium further led to bleeding.

Entities:  

Keywords:  Abnormal uterine bleeding; Human endometrium; Primary endometrial disorder; Proteomic analysis

Year:  2021        PMID: 33653363     DOI: 10.1186/s12958-021-00713-4

Source DB:  PubMed          Journal:  Reprod Biol Endocrinol        ISSN: 1477-7827            Impact factor:   5.211


  1 in total

1.  Study of the Efficacy of Pipelle Biopsy Technique to Diagnose Endometrial Diseases in Abnormal Uterine Bleeding.

Authors:  C Raja Ilavarasi; G S Jyothi; Nanda Kishore Alva
Journal:  J Midlife Health       Date:  2019 Apr-Jun
  1 in total
  1 in total

1.  Discovery of NEU1 as a candidatedone. renal biomarker for proliferative lupus nephritis chronicity.

Authors:  Zhaomin Mao; Ying Tan; Feng Yu; Minghui Zhao
Journal:  Lupus Sci Med       Date:  2021-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.